Why the study?
Methotrexate has a narrow therapeutic index and, if unmonitored, can lead to life-threatening complications.
Unmonitored methotrexate therapy and dosing errors can lead to life-threatening complications including ventricular arrhythmia and cardiogenic shock.
Answers are grounded in this paper and cite their sources.
Dosing errors with methotrexate warrant heightened vigilance; this case leaves open the need for systematic safety protocols.
Methotrexate (MTX) is the most widely used drug in clinical practice for long term treatment of connective tissue disorders. As this drug has narrow therapeutic index, if it goes unmonitored can lead to life threatening complications. Herein we are describing the case of a patient who presented with ventricular arrhythmia, due to failure to execute MTX therapy in the prescribed frequency and took daily dose of MTX which was meant to be taken as a weekly dose pointing to failure of patient education or patient comprehension regarding MTX and finally succumbed due to cardiogenic shock. We concluded this causality as probable/likely category according to WHO-UMC causality categories.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: